To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
News | Article
For more than 30 years, the Service of Pharmacology and Immunoanalysis (SPI) of the CEA's Frédéric Joliot Institute offers its expertise in the development of immunoanalytical methods, physicochemical analyzes (LC-MS), genetic detection ( PCR) and cell culture allowing it to address the detection, quantification and fate of potentially dangerous molecules or microorganisms. Since 2005, his research in the field of biosafety has been supported by the interdepartmental R&D program NRBC-E, entrusted by public authorities to the CEA.
In early 2017, the DRF management launched a new call for projects whose aim is to stimulate changes or new interactions between its institutes. This year, management has decided to consolidate and strengthen all of its incentive actions into one larger program. Research Teams at the Frédéric Joliot Institute have been very active in getting involved.
On the 5th, 6th and 7th of July the first PhD students Days of the Institute of life sciences Frédéric Joliot were held. In the spirit of the previous PhD students Days that took place each year at IBITECS and I2BM, PhD students and researchers met for three half days to discuss about their work.
Last May, we showed you almost live the extraordinary journey of the magnet from Belfort to Saclay, and his arrival on the 18th of May. What happened later?
The "First international course on PET in Epilepsy", organized by the SHFJ in early June, brought together about thirty international specialists in the field. The challenge was to disseminate know-how widely developed at SHFJ: the pre-surgical localization of epileptic foci by PET in patients with focal drug-resistant epilepsies, candidates for resection neurosurgery.
Winfried Leibl (SB2SM) is a member of the steering committee of the MOMENTOM project (MOlecules and Materials for the ENergy of TOMorrow, IRS PARIS-SACLAY, 2017-2020) This project, funded within the framework of the Strategic Research Initiatives (IRS) of Paris-Saclay University, concerns molecules and materials for the energy of tomorrow.
Got it ! Thursday, the 18th of May 2017, at 9:30 pm, the 11.7 Tesla magnet of the Iseult project joined the CEA, after a journey started on the 4th of May in Belfort, to be installed at NeuroSpin.
After its creation by Michel Léonetti, a researcher at SPI / LERI, and Luc Boblet, external holder at the CEA, backed by the IDEX Paris-Saclay funding among other things, the H-Immune start-up recently signed a partnership agreement with the Pierre Fabre Innovation Fund to develop cancer immunotherapy treatments.
On Thursday, May 4, a giant magnet weighing 130 metric tons will leave the assembly plants in Belfort on its journey to the NeuroSpin research facility at the CEA's Paris-Saclay Center (Essonne).
The CEA Frédéric Joliot Institute is involved in project CARBAMAT to fight against antibiotic resistance. SATT Paris-Saclay, a company promoting technology transfer, supports this project.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.